exit_to_appLogin
forum

ERIS Share Price Discussion

Eris Lifesciences Ltd.
Sector: Pharmaceuticals and health care
... Read more
ERIS Share Price *
410.05 +2.4 (0.59%)
* (quote may be delayed)

ERIS Discussion Forum

NewsBot @newsbot
 in 
ERIS
•
Jul 31 5:08 PM
Accumulate Eris Lifesciences; target of Rs 459: Prabhudas Lilladher
Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 459 in its research report dated July 29, 2019.
www.moneycontrol.com
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
ERIS
•
Jul 29 6:33 PM
Eris Life Standalone June 2019 Net Sales at Rs 262.33 crore, up 15.82% Y-o-Y
moneycontrol.com
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
ERIS
•
Jul 29 2:13 PM
Stocks in the news: ICICI Bank, Cadila Health, Mahindra Life, Vedanta, Uflex, Granules, NHPC
Maruti Suzuki | Allahabad Bank | Future Lifestyle Fashions | ICICI Bank | Power Mech Projects | Manpasand Beverages and Usha Martin are stocks which are in news today.
www.moneycontrol.com
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
ERIS
•
Jul 22 12:48 AM
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
ERIS
•
Jul 12 10:33 PM
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
ERIS
•
Jun 25 3:08 PM
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
ERIS
•
Jun 25 1:13 PM
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
ERIS
•
Jun 17 12:58 AM
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
ERIS
•
May 22 1:18 PM
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
ERIS
•
May 22 12:58 AM
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
ERIS
•
May 21 10:28 PM
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
ERIS
•
Apr 18 1:13 PM
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
ERIS
•
Apr 12 6:48 PM
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
ERIS
•
Apr 8 1:23 PM
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
ERIS
•
Apr 8 12:43 AM
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
ERIS
•
Jan 30 5:57 PM
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
ERIS
•
Jan 29 10:02 PM
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
ERIS
•
Jan 4 2:42 AM
Like
reply
Reply
share
Share
NewsBot @newsbot
 in 
ERIS
•
Nov 14 10:47 PM
Like
reply
Reply
share
Share

  • ERIS - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization8,855.69
    Enterprise Value8,849.22
    Price to Earnings37.17
    Price to Book Value7.66
    Return on Capital Employed0.26
    Return on Equity0.34
    Face Value1
    Dividend YieldNA

  • ERIS Share Price - Technicals

    keyboard_arrow_down
    ERIS - 52 Week High₹780.2
    ERIS - 52 Week Low₹358.1

  • ERIS - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    29-Jul-19Prabhudas LilladherAccumulate459
    30-Jan-19Prabhudas LilladherAccumulate695
    6-Nov-18Prabhudas LilladherAccumulate704
    22-Oct-18AnandRathiBuy879
    28-May-18Prabhudas LilladherAccumulate885
    View all ERIS - Share Targets - Broker Reports

  • ERIS Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 18410.8417.4404.15411.35
    Sep 17421.8432.35403.25407.65
    Sep 16424.8429.95409.85423.05
    Sep 13426435.95420.1424.8
    Sep 12395443.95394422

  • ERIS Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹394.29
    30 Day Moving Average₹396.63
    50 Day Moving Average₹413.76
    100 Day Moving Average₹482.89
    200 Day Moving Average₹564.59

  • ERIS - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue761688.370.11
    Operating Profit316270.450.17
    Profit Before Tax312266.230.17
    Net Income294242.570.21

  • ERIS - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds1,1568680.33
    Total Liabilities314528-0.41
    Total Assets1,4701,3970.05

  • ERIS - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity236185.170.27
    Cash from Investing Activity-593-174.132.41
    Cash from Financing Activity363-17.52-21.72
    Net Cash Flow7-6.48-2.08

  • ERIS - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.210.39
    Return on Equity0.340.44
    Return on Capital Employed0.260.49

  • ERIS - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.39
    3 Year CAGR Growth in Operating Profit1.78
    3 Year CAGR Growth in EBIDTA1.93
    3 Year CAGR Growth in Net Income2.53
    3 Yr CAGR Growth - Diluted EPS-0.96

  • ERIS - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.82
    5 Year CAGR Growth in Operating Profit2.45
    5 Year CAGR Growth in EBIDTA2.69
    5 Year CAGR Growth in Net Income3.47
    3 Yr CAGR Growth - Diluted EPS-0.95

  • ERIS Share Price - Recent News

    keyboard_arrow_down
    NewsBot
    Jul 31 5:08 PM
    Accumulate Eris Lifesciences; target of Rs 459: Prabhudas Lilladher
    www.moneycontrol.com
    NewsBot
    Jul 29 6:33 PM
    Eris Life Standalone June 2019 Net Sales at Rs 262.33 crore, up 15.82% Y-o-Y
    moneycontrol.com
    NewsBot
    Jul 29 2:13 PM
    Stocks in the news: ICICI Bank, Cadila Health, Mahindra Life, Vedanta, Uflex, Granules, NHPC
    www.moneycontrol.com
    NewsBot
    Jul 22 12:48 AM
    NewsBot
    Jul 12 10:33 PM
    NewsBot
    Jun 25 3:08 PM
    NewsBot
    Jun 25 1:13 PM
    NewsBot
    Jun 17 12:58 AM
    NewsBot
    May 22 1:18 PM
    NewsBot
    May 22 12:58 AM

  • ERIS - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.
HelpAboutPrivacyTermsDisclaimersRefunds